PPARG: Gene expression regulation and next-generation sequencing for unsolved issues

PPAR Research

Volumn , Issue , 2010, Pages

  Ciccodicola, Alfredo ^a   Costa, Valerio ^a   Gallo, Maria Assunta ^b   Letizia, Francesca ^a   Aprile, Marianna ^a   Casamassimi, Amelia ^a,c  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b Centro Diagnostico San Ciro (CDS)   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPROTEIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN;

ABDOMINAL FAT; ADIPOGENESIS; ATHEROSCLEROSIS; BODY FAT; BODY MASS; BONE MINERAL; COLORECTAL CANCER; CONFORMATIONAL TRANSITION; DYSLIPIDEMIA; FAMILIAL PARTIAL LIPODYSTROPHY; FATTY LIVER; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID METABOLISM; MEDICAL TECHNOLOGY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PLEIOTROPY; PROTEIN FUNCTION; REVIEW; RNA SEQUENCE; TRANSCRIPTION INITIATION;

EID: 77957933414     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/409168     Document Type: Review

References (149)

1. Perissi V., Rosenfeld M. G., Controlling nuclear receptors: the circular logic of cofactor cycles Nature Reviews Molecular Cell Biology 2005 6 7 542 554
2. Farnham P. J., Insights from genomic profiling of transcription factors Nature Reviews Genetics 2009 10 9 605 616
3. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schtz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M., The nuclear receptor super-family: the second decade Cell 1995 83 6 835 839
4. Renaud J. P., Moras D., Structural studies on nuclear receptors Cellular and Molecular Life Sciences 2000 57 12 1748 1769
5. Berger J., Moller D. E., The mechanisms of action of PPARs Annual Review of Medicine 2002 53 409 435
6. Torchia J., Glass C., Rosenfeld M. G., Co-activators and co-repressors in the integration of transcriptional responses Current Opinion in Cell Biology 1998 10 3 373 383
7. Knouff C., Auwerx J., Peroxisome proliferator-activated receptor- calls for activation in moderation: lessons from genetics and pharmacology Endocrine Reviews 2004 25 6 899 918
8. Braissant O., Foufelle F., Scotto C., Daua M., Wahli W., Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-,-, and- in the adult rat Endocrinology 1996 137 1 354 366
9. Michalik L., Wahli W., Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions Current Opinion in Biotechnology 1999 10 6 564 570
10. Sher T., Yi H.-F., McBride O. W., Gonzalez F. J., cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor Biochemistry 1993 32 21 5598 5604
11. Yoshikawa T., Brkanac Z., Dupont B. R., Xing G.-Q., Leach R. J., Detera-Wadleigh S. D., Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2 Genomics 1996 35 3 637 638
12. Francis G. A., Fayard E., Picard F., Auwerx J., Nuclear receptors and the control of metabolism Annual Review of Physiology 2003 65 261 311
13. IJpenberg A., Jeannin E., Wahli W., Desvergne B., Polarity and specific sequence requirements of peroxisome proliferator- activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element Journal of Biological Chemistry 1997 272 32 20108 20117
14. Rosen E. D., Sarraf P., Troy A. E., Bradwin G., Moore K., Milstone D. S., Spiegelman B. M., Mortensen R. M., PPAR is required for the differentiation of adipose tissue in vivo and in vitro Molecular Cell 1999 4 4 611 617
15. Zhou J., Wilson K. M., Medh J. D., Genetic analysis of four novel peroxisome proliferator activated receptor- splice variants in monkey macrophages Biochemical and Biophysical Research Communications 2002 293 1 274 283
16. McClelland S., Shrivastava R., Medh J. D., Regulation of translational efficiency by disparate 5′ -UTRs of PPAR splice variants PPAR Research 2009 2009 8
17. Zhu Y., Qi C., Korenberg J. R., Chen X.-N., Noya D., Sambasiva Rao M., Reddy J. K., Structural organization of mouse peroxisome proliferator-activated receptor (mPPAR ) gene: alternative promoter use and different splicing yield two mPPAR isoforms Proceedings of the National Academy of Sciences of the United States of America 1995 92 17 7921 7925
18. Fajas L., Auboeuf D., Rasp E., Schoonjans K., Lefebvre A.-M., Saladin R., Najib J., Laville M., Fruchart J.-C., Deeb S., Vidal-Puig A., Flier J., Briggs M. R., Staels B., Vidal H., Auwerx J., The organization, promoter analysis, and expression of the human PPAR gene Journal of Biological Chemistry 1997 272 30 18779 18789
19. Tontonoz P., Hu E., Spiegelman B. M., Stimulation of adipogenesis in fibroblasts by PPAR 2, a lipid-activated transcription factor Cell 1994 79 7 1147 1156
20. Vidal-Puig A. J., Considine R. V., Jimenez-Lian M., Werman A., Pories W. J., Caro J. F., Flier J. S., Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids Journal of Clinical Investigation 1997 99 10 2416 2422
21. Sabatino L., Casamassimi A., Peluso G., Barone M. V., Capaccio D., Migliore C., Bonelli P., Pedicini A., Febbraro A., Ciccodicola A., Colantuoni V., A novel peroxisome proliferator-activated receptor isoform with dominant negative activity generated by alternative splicing Journal of Biological Chemistry 2005 280 28 26517 26525
22. Kim H. J., Woo I. S., Kang E. S., Eun S. Y., Kim H. J., Lee J. H., Chang K. C., Kim J.-H., Seo H. G., Identification of a truncated alternative splicing variant of human PPAR 1 that exhibits dominant negative activity Biochemical and Biophysical Research Communications 2006 347 3 698 706
23. Costa V., Casamassimi A., Ciccodicola A., Nutritional genomics era: opportunities toward a genome-tailored nutritional regimen Journal of Nutritional Biochemistry 2010 21 6 457 467
24. McKenna N. J., O'Malley B. W., Combinatorial control of gene expression by nuclear receptors and coregulators Cell 2002 108 4 465 474
25. Kliewer S. A., Sundseth S. S., Jones S. A., Brown P. J., Wisely G. B., Koble C. S., Devchand P., Wahli W., Willson T. M., Lenhard J. M., Lehmann J. M., Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors and Proceedings of the National Academy of Sciences of the United States of America 1997 94 9 4318 4323
26. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., Evans R. M., PPAR- dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation Nature Medicine 2001 7 1 48 52
27. Chandra V., Huang P., Hamuro Y., Raghuram S., Wang Y., Burris T. P., Rastinejad F., Structure of the intact PPAR- -RXR- nuclear receptor complex on DNA Nature 2008 456 7220 350 356
28. Nielsen R., Pedersen T.., Hagenbeek D., Moulos P., Siersbk R., Megens E., Denissov S., Brgesen M., Francoijs K.-J., Mandrup S., Stunnenberg H. G., Genome-wide profiling of PPAR :RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis Genes and Development 2008 22 21 2953 2967
29. Madsen L., Petersen R. K., Srensen M. B., Jrgensen C., Hallenborg P., Pridal L., Fleckner J., Amri E.-Z., Krieg P., Furstenberger G., Berge R. K., Kristiansen K., Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process Biochemical Journal 2003 375 3 539 549
30. Tzameli I., Fang H., Ollero M., Shi H., Hamm J. K., Kievit P., Hollenberg A. N., Flier J. S., Regulated production of a peroxisome proliferator-activated receptor- ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes Journal of Biological Chemistry 2004 279 34 36093 36102
31. Lefterova M. I., Steger D. J., Zhuo D., Qatanani M., Mullican S. E., Tuteja G., Manduchi E., Grant G. R., Lazar M. A., Cell-specific determinants of peroxisome proliferator-activated receptor function in adipocytes and macrophages Molecular and Cellular Biology 2010 30 9 2078 2089
32. Dilworth F. J., Chambon P., Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription Oncogene 2001 20 24 3047 3054
33. Ho L., Crabtree G. R., Chromatin remodelling during development Nature 2010 463 7280 474 484
34. Strahl B. D., Allis C. D., The language of covalent histone modifications Nature 2000 403 6765 41 45
35. Zhang Y., Reinberg D., Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails Genes and Development 2001 15 18 2343 2360
36. Sims R. J. III, Nishioka K., Reinberg D., Histone lysine methylation: a signature for chromatin function Trends in Genetics 2003 19 11 629 639
37. Kouzarides T., Chromatin modifications and their function Cell 2007 128 4 693 705
38. Scotti E., Tontonoz P., Peroxisome proliferator-activated receptor dances with different partners in macrophage and adipocytes Molecular and Cellular Biology 2010 30 9 2076 2077
39. Ge K., Guermah M., Yuan C.-X., Ito M., Wallberg A. E., Spiegelman B. M., Roeder R. G., Transcription coactivator TRAP220 is required for PPAR 2-stimulated adipogenesis Nature 2002 417 6888 563 567
40. Zhu Y., Qi C., Jain S., Rao M. S., Reddy J. K., Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor Journal of Biological Chemistry 1997 272 41 25500 25506
41. Heinlein C. A., Ting H.-J., Yeh S., Chang C., Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor Journal of Biological Chemistry 1999 274 23 16147 16152
42. Lee S.-K., Anzick S. L., Choi J.-E., Bubendorf L., Guan X.-Y., Jung Y.-K., Kallioniemi O. P., Kononen J., Trent J. M., Azorsa D., Jhun B.-H., Cheong J. H., Lee Y. C., Meltzer P. S., Lee J. W., A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo Journal of Biological Chemistry 1999 274 48 34283 34293
43. Jepsen K., Rosenfeld M. G., Biological roles and mechanistic actions of corepressor complexes Journal of Cell Science 2002 115 4 689 698
44. Li J., Lin Q., Yoon H.-G., Huang Z.-Q., Strahl B. D., Allis C. D., Wong J., Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor Molecular and Cellular Biology 2002 22 16 5688 5697
45. Hu X., Li Y., Lazar M. A., Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors Molecular and Cellular Biology 2001 21 5 1747 1758
46. Treuter E., Albrektsen T., Johansson L., Leers J., Gustafsson J.-A., A regulatory role for RIP140 in nuclear receptor activation Molecular Endocrinology 1998 12 6 864 881
47. Pascual G., Fong A. L., Ogawa S., Gamliel A., Li A. C., Perissi V., Rose D. W., Willson T. M., Rosenfeld M. G., Glass C. K., A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR- Nature 2005 437 7059 759 763
48. Kielian T., Drew P. D., Effects of peroxisome proliferator-activated receptor- agonists on central nervous system inflammation Journal of Neuroscience Research 2003 71 3 315 325
49. Hummasti S., Tontonoz P., The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis Molecular Endocrinology 2006 20 6 1261 1275
50. Werman A., Hollenberg A., Solanes G., Bjrbk C., Vidal-Puig A. J., Flier J. S., Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor (PPAR ). Differential activity of PPAR 1 and -2 isoforms and influence of insulin Journal of Biological Chemistry 1997 272 32 20230 20235
51. Saladin R., Fajas L., Dana S., Halvorsen Y.-D., Auwerx J., Briggs M., Differential regulation of peroxisome proliferator activated receptor 1 (PPAR 1) and PPAR 2 messenger RNA expression in the early stages of adipogenesis Cell Growth and Differentiation 1999 10 1 43 48
52. Lehrke M., Lazar M. A., The many faces of PPAR Cell 2005 123 6 993 999
53. Barak Y., Nelson M. C., Ong E. S., Jones Y. Z., Ruiz-Lozano P., Chien K. R., Koder A., Evans R. M., PPAR is required for placental, cardiac, and adipose tissue development Molecular Cell 1999 4 4 585 595
54. Jones J. R., Barrick C., Kim K.-A., Lindner J., Blondeau B., Fujimoto Y., Shiota M., Kesterson R. A., Kahn B. B., Magnuson M. A., Deletion of PPAR in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance Proceedings of the National Academy of Sciences of the United States of America 2005 102 17 6207 6212
55. Koutnikova H., Cock T.-A., Watanabe M., Houten S. M., Champy M.-F., Dierich A., Auwerx J., Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR hypomorphic mice Proceedings of the National Academy of Sciences of the United States of America 2003 100 24 14457 14462
56. Zhang J., Fu M., Cui T., Xiong C., Xu K., Zhong W., Xiao Y., Floyd D., Liang J., Li E., Song Q., Chen Y. E., Selective disruption of PPAR 2 impairs the development of adipose tissue and insulin sensitivity Proceedings of the National Academy of Sciences of the United States of America 2004 101 29 10703 10708
57. Altshuler D., Hirschhorn J. N., Klannemark M., Lindgren C. M., Vohl M.-C., Nemesh J., Lane C. R., Schaffner S. F., Bolk S., Brewer C., Tuomi T., Gaudet D., Hudson T. J., Daly M., Groop L., Lander E. S., The common PPAR Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes Nature Genetics 2000 26 1 76 80
58. Medina-Gomez G., Virtue S., Lelliott C., Boiani R., Campbell M., Christodoulides C., Perrin C., Jimenez-Linan M., Blount M., Dixon J., Zahn D., Thresher R. R., Aparicio S., Carlton M., Colledge W. H., Kettunen M. I., Seppnen-Laakso T., Sethi J. K., O'Rahilly S., Brindle K., Cinti S., Orei M., Burcelin R., Vidal-Puig A., The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor- 2 isoform Diabetes 2005 54 6 1706 1716
59. Miles P. D. G., Barak Y., He W., Evans R. M., Olefsky J. M., Improved insulin-sensitivity in mice heterozygous for PPAR- deficiency Journal of Clinical Investigation 2000 105 3 287 292
60. Miles P. D. G., Barak Y., Evans R. M., Olefsky J. M., Effect of heterozygous PPAR deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding American Journal of PhysiologyEndocrinology and Metabolism 2003 284 3 E618 E626
61. Anghel S. I., Bedu E., Vivier C. D., Descombes P., Desvergne B., Wahli W., Adipose tissue integrity as a prerequisite for systemic energy balance: a critical role for peroxisome proliferator-activated receptor Journal of Biological Chemistry 2007 282 41 29946 29957
62. Rieusset J., Seydoux J., Anghel S. I., Escher P., Michalik L., Tan N. S., Metzger D., Chambon P., Wahli W., Desvergne B., Altered growth in male peroxisome proliferator-activated receptor (PPAR ) heterozygous mice: involvement of PPAR in a negative feedback regulation of growth hormone action Molecular Endocrinology 2004 18 10 2363 2377
63. He W., Barak Y., Hevener A., Olson P., Liao D., Le J., Nelson M., Ong E., Olefsky J. M., Evans R. M., Adipose-specific peroxisome proliferator-activated receptor knockout causes insulin resistance in fat and liver but not in muscle Proceedings of the National Academy of Sciences of the United States of America 2003 100 26 15712 15717
64. Hirakata M., Tozawa R., Imura Y., Sugiyama Y., Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation Biochemical and Biophysical Research Communications 2004 323 3 782 788
65. Tontonoz P., Nagy L., Alvarez J. G. A., Thomazy V. A., Evans R. M., PPAR promotes monocyte/macrophage differentiation and uptake of oxidized LDL Cell 1998 93 2 241 252
66. Akiyama T. E., Sakai S., Lambert G., Nicol C. J., Matsusue K., Pimprale S., Lee Y.-H., Ricote M., Glass C. K., Brewer H. B. Jr., Gonzalez F. J., Conditional disruption of the peroxisome proliferator-activated receptor gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux Molecular and Cellular Biology 2002 22 8 2607 2619
67. Babaev V. R., Yancey P. G., Ryzhov S. V., Kon V., Breyer M. D., Magnuson M. A., Fazio S., Linton M. F., Conditional knockout of macrophage PPAR increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 8 1647 1653
68. De Luca C., Olefsky J. M., Stressed out about obesity and insulin resistance Nature Medicine 2006 12 1 41 42
69. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue Journal of Clinical Investigation 2003 112 12 1796 1808
70. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance Journal of Clinical Investigation 2003 112 12 1821 1830
71. Heikkinen S., Auwerx J., Argmann C. A., PPAR in human and mouse physiology Biochimica et Biophysica Acta 2007 1771 8 999 1013
72. He W., PPAR 2 Pro12Ala polymorphism and human health PPAR Research 2009 2009 15
73. Deeb S. S., Fajas L., Nemoto M., Pihlajamki J., Mykknen L., Kuusisto J., Laakso M., Fujimoto W., Auwerx J., A Pro12Ala substitution in PPAR 2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Nature Genetics 1998 20 3 284 287
74. Barroso I., Gurnell M., Crowley V. E. F., Agostini M., Schwabe J. W., Soos M. A., Maslen G. L., Williams T. D. M., Lewis H., Schafer A. J., Chatterjee V. K. K., O'Rahilly S., Dominant negative mutations in human PPAR associated with severe insulin resistance, diabetes mellitus and hypertension Nature 1999 402 6764 880 883
75. Masugi J., Tamori Y., Mori H., Koike T., Kasuga M., Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator- activated receptor- 2 on thiazolidinedione-induced adipogenesis Biochemical and Biophysical Research Communications 2000 268 1 178 182
76. Savage D. B., Agostini M., Barroso I., Gurnell M., Luan J., Meirhaeghe A., Harding A.-H., Ihrke G., Rajanayagam O., Soos M. A., George S., Berger D., Thomas E. L., Bell J. D., Meeran K., Ross R. J., Vidal-Puig A., Wareham N. J., O'Rahilly S., Chatterjee V. K. K., Schafer A. J., Digenic inheritance of severe insulin resistance in a human pedigree Nature Genetics 2002 31 4 379 384
77. Hegele R. A., Cao H., Frankowski C., Mathews S. T., Leff T., PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy Diabetes 2002 51 12 3586 3590
78. Kolehmainen M., Uusitupa M. I. J., Alhava E., Laakso M., Vidal H., Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) 2 gene on the expression of PPAR target genes in adipose tissue of massively obese subjects Journal of Clinical Endocrinology and Metabolism 2003 88 4 1717 1722
79. Muller Y. L., Bogardus C., Beamer B. A., Shuldiner A. R., Baier L. J., A functional variant in the peroxisome proliferatoractivated receptor 2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians Diabetes 2003 52 7 1864 1871
80. Al-Shali K., Cao H., Knoers N., Hermus A. R., Tack C. J., Hegele R. A., A single-base mutation in the peroxisome proliferator-activated receptor 4 promoter associated with altered in vitro expression and partial lipodystrophy Journal of Clinical Endocrinology and Metabolism 2004 89 11 5655 5660
81. Agostini M., Gurnell M., Savage D. B., Wood E. M., Smith A. G., Rajanayagam O., Garnes K. T., Levinson S. H., Xu H. E., Schwabe J. W. R., Willson T. M., O'Rahilly S., Chatterjee V. K., Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor Endocrinology 2004 145 4 1527 1538
82. Agostini M., Schoenmakers E., Mitchell C., Szatmari I., Savage D., Smith A., Rajanayagam O., Semple R., Luan J., Bath L., Zalin A., Labib M., Kumar S., Simpson H., Blom D., Marais D., Schwabe J., Barroso I., Trembath R., Wareham N., Nagy L., Gurnell M., O'Rahilly S., Chatterjee K., Non-DNA binding, dominant-negative, human PPAR mutations cause lipodystrophic insulin resistance Cell Metabolism 2006 4 4 303 311
83. Heikkinen S., Argmann C., Feige J. N., Koutnikova H., Champy M.-F., Dali-Youcef N., Schadt E. E., Laakso M., Auwerx J., The Pro12Ala PPAR 2 variant determines metabolism at the gene-environment interface Cell Metabolism 2009 9 1 88 98
84. Capaccio D., Ciccodicola A., Sabatino L., Casamassimi A., Pancione M., Fucci A., Febbraro A., Merlino A., Graziano G., Colantuoni V., A novel germline mutation in peroxisome proliferator-activated receptor gene associated with large intestine polyp formation and dyslipidemia Biochimica et Biophysica Acta 2010 1802 6 572 581
85. Mori H., Ikegami H., Kawaguchi Y., Seino S., Yokoi N., Takeda J., Inoue I., Seino Y., Yasuda K., Hanafusa T., Yamagata K., Awata T., Kadowaki T., Hara K., Yamada N., Gotoda T., Iwasaki N., Iwamoto Y., Sanke T., Nanjo K., Oka Y., Matsutani A., Maeda E., Kasuga M., The Pro12→Ala substitution in PPAR- is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes Diabetes 2001 50 4 891 894
86. Masud S., Ye S., Effect of the peroxisome proliferates activated receptor- gene Pro12Ala variant on body mass index: a meta-analysis Journal of Medical Genetics 2003 40 10 773 780
87. Doney A. S. F., Fischer B., Cecil J. E., Boylan K., McGuigan F. E., Ralston S. H., Morris A. D., Palmer C. N. A., Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes Diabetologia 2004 47 3 555 558
88. Costa V., Casamassimi A., Esposito K., Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy Journal of Biomedicine and Biotechnology 2009 2009 7
89. Chistiakov D. A., Potapov V. A., Khodirev D. S., Shamkhalova M. S., Shestakova M. V., Nosikov V. V., The PPAR Pro12Ala variant is associated with insulin sensitivity in Russian normoglycaemic and type 2 diabetic subjects Diabetes and Vascular Disease Research 2010 7 1 56 62
90. Meirhaeghe A., Fajas L., Helbecque N., Cottel D., Lebel P., Dallongeville J., Deeb S., Auwerx J., Amouyel P., A genetic polymorphism of the peroxisome proliferator-activated receptor gene influences plasma leptin levels in obese humans Human Molecular Genetics 1998 7 3 435 440
91. Valve R., Sivenius K., Miettinen R., Pihlajamki J., Rissanen A., Deeb S. S., Auwerx J., Uusitupa M., Laakso M., Two polymorphisms in the peroxisome proliferator-activated receptor- gene are associated with severe overweight among obese women Journal of Clinical Endocrinology and Metabolism 1999 84 10 3708 3712
92. Simn I., Vendrell J., Gutirrez C., Fernndez-Real J.M., Vendrell I., Gallart Ll., Fontova R., Richart C., Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus Hormone Research 2002 58 3 143 149
93. Schneider J., Kreuzer J., Hamann A., Nawroth P. P., Dugi K. A., The proline 12 alanine substitution in the peroxisome proliferator-activated receptor- 2 gene is associated with lower lipoprotein lipase activity in vivo Diabetes 2002 51 3 867 870
94. Yamamoto Y., Hirose H., Miyashita K., Nishikai K., Saito I., Taniyama M., Tomita M., Saruta T., PPAR 2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population Metabolism 2002 51 11 1407 1409
95. Meirhaeghe A., Fajas L., Gouilleux F., Cottel D., Helbecque N., Auwerx J., Amouyel P., A functional polymorphism in a STAT5B site of the human PPAR 3 gene promoter affects height and lipid metabolism in a French population Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 2 289 294
96. Takata N., Awata T., Inukai K., Watanabe M., Ohkubo T., Kurihara S., Inaba M., Katayama S., Pro12Ala substitution in peroxisome proliferator- activated receptor 2 is associated with low adiponectin concentrations in young Japanese men Metabolism 2004 53 12 1548 1551
97. Wang C., Zhai F., Chi Y., Wang G., Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population Wei Sheng Yan Jiu 2004 33 3 317 320
98. Orio F. Jr., Palomba S., Cascella T., Di Biase S., Labella D., Russo T., Savastano S., Zullo F., Colao A., Vettor R., Lombardi G., Lack of an association between peroxisome proliferator-activated receptor- gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 2004 89 10 5110 5115
99. Meirhaeghe A., Cottel D., Amouyel P., Dallongeville J., Association between peroxisome proliferator-activated receptor haplotypes and the metabolic syndrome in French men and women Diabetes 2005 54 10 3043 3048
100. Bidziska-Speichert B., Demissie M., Tworowska U., Slezak R., Dobosz T., Bednarek-Tupikowska G., Milewicz A., Leptin level and the PPARgamma2 Pro12Ala and Pro115Gln polymorphisms in women with functional hyperandrogenism. Preliminary report Przeglad Lekarski 2005 62 9 833 837
101. Radha V., Vimaleswaran K. S., Babu S., Deepa R., Anjana M., Ghosh S., Majumder P. P., Rao M. R.S., Mohan V., Lack of association between serum adiponectin levels and the Pro12Ala polymorphism in Asian Indians Diabetic Medicine 2007 24 4 398 402
102. Haseeb A., Iliyas M., Chakrabarti S., Farooqui A. A., Naik S. R., Ghosh S., Suragani M., Ehtesham N. Z., Single-nucleotide polymorphisms in peroxisome proliferator-activated receptor gamma and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population Journal of Biosciences 2009 34 3 405 414
103. Doney A. S. F., Fischer B., Leese G., Morris A. D., Palmer C. N. A., Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a go-DARTS study Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 12 2403 2407
104. Mancini F. P., Vaccaro O., Sabatino L., Tufano A., Rivellese A. A., Riccardi G., Colantuoni V., Pro12Ala substitution in the peroxisome proliferator-activated receptor- 2 is not associated with type 2 diabetes Diabetes 1999 48 7 1466 1468
105. Sanghera D. K., Demirci F. Y., Been L., Ortega L., Ralhan S., Wander G. S., Mehra N. K., Singh J., Aston C. E., Mulvihill J. J., Kamboh I. M., PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor Metabolism 2010 59 4 492 501
106. Rhee E. J., Oh K. W., Lee W. Y., Kim S. Y., Oh E. S., Baek K. H., Kang M. I., Kim S. W., Effects of two common polymorphisms of peroxisome proliferator-activated receptor- gene on metabolic syndrome Archives of Medical Research 2006 37 1 86 94
107. Tai E. S., Corella D., Deurenberg-Yap M., Adiconis X., Chew S. K., Tan C. E., Ordovas J. M., Differential effects of the C1431T and Pro12Ala PPAR gene variants on plasma lipids and diabetes risk in an Asian population Journal of Lipid Research 2004 45 4 674 685
108. Ristow M., Mller-Wieland D., Pfeiffer A., Krone W., Kahn C. R., Obesity associated with a mutation in a genetic regulator of adipocyte differentiation New England Journal of Medicine 1998 339 14 953 959
109. Agarwal A. K., Garg A., A novel heterozygous mutation in peroxisome proliferator-activated receptor- gene in a patient with familial partial lipodystrophy Journal of Clinical Endocrinology and Metabolism 2002 87 1 408 411
110. Gouda H. N., Sagoo G. S., Harding A.-H., Yates J., Sandhu M. S., Higgins J. P. T., The association between the peroxisome proliferator-activated receptor- 2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis American Journal of Epidemiology 2010 171 6 645 655
111. Zheng T.-Y., Lin Y.-J., Horng J.-C., Thermodynamic consequences of incorporating 4-substituted proline derivatives into a small helical protein Biochemistry 2010 49 19 4255 4263
112. Clement K., Hercberg S., Passinge B., Galan P., Varroud-Vial M., Shuldiner A. R., Beamer B. A., Charpentier G., Guy-Grand B., Froguel P., Vaisse C., The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes International Journal of Obesity 2000 24 3 391 393
113. Agstsson T. T., Hkonarson H., Olafsson I., Hjaltadttir G., Thornrsson A. V., A mutation detection in a transcription factor for adipocyte development in children with severe obesity Laeknabladid 2001 87 2 119 124
114. Hamer O. W., Forstner D., Ottinger I., Ristow M., Bollheimer L. C., Schlmerich J., Palitzsch K. D., The pro115Gln polymorphism within the PPAR 2 gene has no epidemiological impact on morbid obesity Experimental and Clinical Endocrinology and Diabetes 2002 110 5 230 234
115. Hadj Mohamed M. B., Mtiraoui N., Ezzidi I., Chaieb M., Mahjoub T., Almawi W. Y., Association of the peroxisome proliferator-activated receptor- 2 Pro12Ala but not the C1431T gene variants with lower body mass index in type 2 diabetes Journal of Endocrinological Investigation 2007 30 11 937 943
116. Stumvoll M., Hring H., The peroxisome proliferator-activated receptor- 2 Pro12Ala polymorphism Diabetes 2002 51 8 2341 2347
117. Lee T. I., Young R. A., Transcription of eukaryotic protein-coding genes Annual Review of Genetics 2000 34 77 137
118. Jimenez-Sanchez G., Childs B., Valle D., Human disease genes Nature 2001 409 6822 853 855
119. Mardis E. R., Next-generation DNA sequencing methods Annual Review of Genomics and Human Genetics 2008 9 387 402
120. Vaquerizas J. M., Kummerfeld S. K., Teichmann S. A., Luscombe N. M., A census of human transcription factors: function, expression and evolution Nature Reviews Genetics 2009 10 4 252 263
121. Costa V., Angelini C., de Feis I., Ciccodicola A., Uncovering the complexity of transcriptomes with RNA-Seq Journal of Biomedicine and Biotechnology 2010 2010 19
122. Metzker M. L., Sequencing technologiesthe next generation Nature Reviews Genetics 2010 11 1 31 46
123. Robertson G., Hirst M., Bainbridge M., Bilenky M., Zhao Y., Zeng T., Euskirchen G., Bernier B., Varhol R., Delaney A., Thiessen N., Griffith O. L., He A., Marra M., Snyder M., Jones S., Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing Nature Methods 2007 4 8 651 657
124. Valouev A., Johnson D. S., Sundquist A., Medina C., Anton E., Batzoglou S., Myers R. M., Sidow A., Genome-wide analysis of transcription factor binding sites based on ChIP-Seq data Nature Methods 2008 5 9 829 834
125. Reddy T. E., Pauli F., Sprouse R. O., Neff N. F., Newberry K. M., Garabedian M. J., Myers R. M., Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation Genome Research 2009 19 12 2163 2171
126. Dahl F., Gullberg M., Stenberg J., Landegren U., Nilsson M., Multiplex amplification enabled by selective circularization of large sets of genomic DNA fragments Nucleic Acids Research 2005 33 8, article e71
127. Fredriksson S., Banr J., Dahl F., Chu A., Ji H., Welch K., Davis R. W., Multiplex amplification of all coding sequences within 10 cancer genes by Gene-Collector Nucleic Acids Research 2007 35 7, article e47
128. Porreca G. J., Zhang K., Li J. B., Xie B., Austin D., Vassallo S. L., LeProust E. M., Peck B. J., Emig C. J., Dahl F., Gao Y., Church G. M., Shendure J., Multiplex amplification of large sets of human exons Nature Methods 2007 4 11 931 936
129. Shendure J., Ji H., Next-generation DNA sequencing Nature Biotechnology 2008 26 10 1135 1145
130. Hodges E., Xuan Z., Balija V., Kramer M., Molla M. N., Smith S. W., Middle C. M., Rodesch M. J., Albert T. J., Hannon G. J., McCombie W. R., Genome-wide in situ exon capture for selective resequencing Nature Genetics 2007 39 12 1522 1527
131. Albert T. J., Molla M. N., Muzny D. M., Nazareth L., Wheeler D., Song X., Richmond T. A., Middle C. M., Rodesch M. J., Packard C. J., Weinstock G. M., Gibbs R. A., Direct selection of human genomic loci by microarray hybridization Nature Methods 2007 4 11 903 905
132. Chou L.-S., Liu C.-S. J., Boese B., Zhang X., Mao R., DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: neurofibromatosis type 1 gene as a model Clinical Chemistry 2010 56 1 62 72
133. Heap G. A., Yang J. H. M., Downes K., Healy B. C., Hunt K. A., Bockett N., Franke L., Dubois P. C., Mein C. A., Dobson R. J., Albert T. J., Rodesch M. J., Clayton D. G., Todd J. A., van Heel D. A., Plagnol V., Genome-wide analysis of allelic expression imbalance in human primary cells by high-throughput transcriptome resequencing Human Molecular Genetics 2010 19 1 122 134
134. Sugarbaker D. J., Richards W. G., Gordon G. J., Dong L., De Rienzo A.,
135. Barrio A. M., Eriksson O., Badhai J., Frjmark A.-S., Bongcam-Rudloff E., Dahl N., Schuster J., Targeted resequencing and analysis of the diamond-blackfan anemia disease locus RPS19 PLoS ONE 2009 4 7, article e6172
136. Park P. J., ChIP-seq: advantages and challenges of a maturing technology Nature Reviews Genetics 2009 10 10 669 680
137. Velculescu V. E., Zhang L., Zhou W., Vogelstein J., Basrai M. A., Bassett D. E. Jr., Hieter P., Vogelstein B., Kinzler K. W., Characterization of the yeast transcriptome Cell 1997 88 2 243 251
138. Birney E., Stamatoyannopoulos J. A., Dutta A., Guig R., Gingeras T. R., Margulies E. H., Weng Z., Snyder M., Dermitzakis E. T., Thurman R. E., Kuehn M. S., Taylor C. M., Neph S., Koch C. M., Asthana S., Malhotra A., Adzhubei I., Greenbaum J. A., Andrews R. M., Flicek P., Boyle P. J., Cao H., Carter N. P., Clelland G. K., Davis S., Day N., Dhami P., Dillon S. C., Dorschner M. O., Fiegler H., Giresi P. G., Goldy J., Hawrylycz M., Haydock A., Humbert R., James K. D., Johnson B. E., Johnson E. M., Frum T. T., Rosenzweig E. R., Karnani N., Lee K., Lefebvre G. C., Navas P. A., Neri F., Parker S. C.J., Sabo P. J., Sandstrom R., Shafer A., Vetrie D., Weaver M., Wilcox S., Yu M., Collins F. S., Dekker J., Lieb J. D., Tullius T. D., Crawford G. E., Sunyaev S., Noble W. S., Dunham I., Denoeud F., Reymond A., Kapranov P., Rozowsky J., Zheng D., Castelo R., Frankish A., Harrow J., Ghosh S., Sandelin A., Hofacker I. L., Baertsch R., Keefe D., Dike S., Cheng J., Hirsch H. A., Sekinger E. A., Lagarde J., Abril J. F., Shahab A., Flamm C., Fried C., Hackermller J., Hertel J., Lindemeyer M., Missal K., Tanzer A., Washietl S., Korbel J., Emanuelsson O., Pedersen J. S., Holroyd N., Taylor R., Swarbreck D., Matthews N., Dickson M. C., Thomas D. J., Weirauch M. T., Gilbert J., Drenkow J., Bell I., Zhao X., Srinivasan K. G., Sung W.-K., Ooi H. S., Chiu K. P., Foissac S., Alioto T., Brent M., Pachter L., Tress M. L., Valencia A., Choo S. W., Choo C. Y., Ucla C., Manzano C., Wyss C., Cheung E., Clark T. G., Brown J. B., Ganesh M., Patel S., Tammana H., Chrast J., Henrichsen C. N., Kai C., Kawai J., Nagalakshmi U., Wu J., Lian Z., Lian J., Newburger P., Zhang X., Bickel P., Mattick J. S., Carninci P., Hayashizaki Y., Weissman S., Hubbard T., Myers R. M., Rogers J., Stadler P. F., Lowe T. M., Wei C.-L., Ruan Y., Struhl K., Gerstein M., Antonarakis S. E., Fu Y., Green E. D., Karaz U., Siepel A., Taylor J., Liefer L. A., Wetterstrand K. A., Good P. J., Feingold E. A., Guyer M. S., Cooper G. M., Asimenos G., Dewey C. N., Hou M., Nikolaev S., Montoya-Burgos J.I., Lytynoja A., Whelan S., Pardi F., Massingham T., Huang H., Zhang N. R., Holmes I., Mullikin J. C., Ureta-Vidal A., Paten B., Seringhaus M., Church D., Rosenbloom K., Kent W. J., Stone E. A., Batzoglou S., Goldman N., Hardison R. C., Haussler D., Miller W., Sidow A., Trinklein N. D., Zhang Z. D., Barrera L., Stuart R., King D. C., Ameur A., Enroth S., Bieda M. C., Kim J., Bhinge A. A., Jiang N., Liu J., Yao F., Vega V. B., Lee C. W.H., Ng P., Yang A., Moqtaderi Z., Zhu Z., Xu X., Squazzo S., Oberley M. J., Inman D., Singer M. A., Richmond T. A., Munn K. J., Rada-Iglesias A., Wallerman O., Komorowski J., Fowler J. C., Couttet P., Bruce A. W., Dovey O. M., Ellis P. D., Langford C. F., Nix D. A., Euskirchen G., Hartman S., Urban A. E., Kraus P., Van Calcar S., Heintzman N., Hoon Kim T., Wang K., Qu C., Hon G., Luna R., Glass C. K., Rosenfeld M. G., Aldred S. F., Cooper S. J., Halees A., Lin J. M., Shulha H. P., Zhang X., Xu M., Haidar J. N.S., Yu Y., Iyer V. R., Green R. D., Wadelius C., Farnham P. J., Ren B., Harte R. A., Hinrichs A. S., Trumbower H., Clawson H., Hillman-Jackson J., Zweig A. S., Smith K., Thakkapallayil A., Barber G., Kuhn R. M., Karolchik D., Armengol L., Bird C. P., De Bakker P. I.W., Kern A. D., Lopez-Bigas N., Martin J. D., Stranger B. E., Woodroffe A., Davydov E., Dimas A., Eyras E., Hallgrmsdttir I. B., Huppert J., Zody M. C., Abecasis G. R., Estivill X., Bouffard G. G., Guan X., Hansen N. F., Idol J. R., Maduro V. V.B., Maskeri B., McDowell J. C., Park M., Thomas P. J., Young A. C., Blakesley R. W., Muzny D. M., Sodergren E., Wheeler D. A., Worley K. C., Jiang H., Weinstock G. M., Gibbs R. A., Graves T., Fulton R., Mardis E. R., Wilson R. K., Clamp M., Cuff J., Gnerre S., Jaffe D. B., Chang J. L., Lindblad-Toh K., Lander E. S., Koriabine M., Nefedov M., Osoegawa K., Yoshinaga Y., Zhu B., De Jong P. J., Identification and analysis of functional elements in 1 of the human genome by the ENCODE pilot project Nature 2007 447 7146 799 816
139. Jacquier A., The complex eukaryotic transcriptome: unexpected pervasive transcription and novel small RNAs Nature Reviews Genetics 2009 10 12 833 844
140. Cloonan N., Forrest A. R. R., Kolle G., Gardiner B. B. A., Faulkner G. J., Brown M. K., Taylor D. F., Steptoe A. L., Wani S., Bethel G., Robertson A. J., Perkins A. C., Bruce S. J., Lee C. C., Ranade S. S., Peckham H. E., Manning J. M., McKernan K. J., Grimmond S. M., Stem cell transcriptome profiling via massive-scale mRNA sequencing Nature Methods 2008 5 7 613 619
141. Marioni J. C., Mason C. E., Mane S. M., Stephens M., Gilad Y., RNA-Seq: an assessment of technical reproducibility and comparison with gene expression arrays Genome Research 2008 18 9 1509 1517
142. Mortazavi A., Williams B. A., McCue K., Schaeffer L., Wold B., Mapping and quantifying mammalian transcriptomes by RNA-Seq Nature Methods 2008 5 7 621 628
143. Nagalakshmi U., Wang Z., Waern K., Shou C., Raha D., Gerstein M., Snyder M., The transcriptional landscape of the yeast genome defined by RNA sequencing Science 2008 320 5881 1344 1349
144. Torres T. T., Metta M., Ottenwlder B., Schltterer C., Gene expression profiling by massively parallel sequencing Genome Research 2008 18 1 172 177
145. Sultan M., Schulz M. H., Richard H., Magen A., Klingenhoff A., Scherf M., Seifert M., Borodina T., Soldatov A., Parkhomchuk D., Schmidt D., O'Keeffe S., Haas S., Vingron M., Lehrach H., Yaspo M.-L., A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome Science 2008 321 5891 956 960
146. Hashimoto S.-I., Qu W., Ahsan B., Ogoshi K., Sasaki A., Nakatani Y., Lee Y., Ogawa M., Ametani A., Suzuki Y., Sugano S., Lee C. C., Nutter R. C., Morishita S., Matsushima K., High-resolution analysis of the 5′ -end transcriptome using a next generation DNA sequencer PLoS ONE 2009 4 1, article e4108
147. Tang F., Barbacioru C., Wang Y., Nordman E., Lee C., Xu N., Wang X., Bodeau J., Tuch B. B., Siddiqui A., Lao K., Surani M. A., mRNA-Seq whole-transcriptome analysis of a single cell Nature Methods 2009 6 5 377 382
148. Wang Z., Gerstein M., Snyder M., RNA-Seq: a revolutionary tool for transcriptomics Nature Reviews Genetics 2009 10 1 57 63
149. B. T. Wilhelm, S. Marguerat, I. Goodhead, and J. Bähler, "Defining transcribed regions using RNA-Seq," Nature Protocols, vol. 5, no. 2, pp. 255-266, 2010.